ZOJWALLA NASEEM (CHIEF MEDICAL OFFICER) sold 32.2% of their position (14.56K shares) of OLEMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $209.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 11/22/2023ACC: 0001415889-23-015459
Officer· CHIEF MEDICAL OFFICER
Since Jan 2022
+13.44K
Net shares
Net buyer
$209.3K
Total sold
3
Open market trades
0B · 3S
4
Total transactions
28K acquired · 14.56K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+28K
Price / share
—
Trade value
—
% of position
162.6%
11/20/2023
17.22K→45.22K
Common Stock
Direct
Shares
−7.26K
Price / share
$14.83
Trade value
$107.68K
% of position
16.1%
11/21/2023
45.22K→37.96K
Common Stock
Direct
Shares
−200.00
Price / share
$15.33
Trade value
$3.07K
% of position
0.5%
11/21/2023
37.96K→37.76K
Common Stock
Direct
Shares
−7.09K
Price / share
$13.89
Trade value
$98.55K
% of position
18.8%
11/22/2023
37.76K→30.66K
Total
Net shares
+13.44K
Net value
-$209.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2023 | A · Award | +28K | — | — | 162.6% | 17.22K | 45.22K |
| Common Stock Direct | 11/21/2023 | S · Sale | −7.26K | $14.83 | $107.68K | 16.1% | 45.22K | 37.96K |
| Common Stock Direct | 11/21/2023 | S · Sale | −200.00 | $15.33 | $3.07K | 0.5% | 37.96K | 37.76K |
| Common Stock Direct | 11/22/2023 | S · Sale | −7.09K | $13.89 | $98.55K | 18.8% | 37.76K | 30.66K |
| Total | +13.44K | -$209.30K | ||||||
Derivative Transactions0
No derivative transactions reported